Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 24 Jan 2020 |
10 | Evidence Affidavit Under Rule 46 (TOP) | 18 Dec 2020 |
11 | Evidence Affidavit Under Rule 46 (TOP) | 18 Dec 2020 |
12 | Annexure -1 under rule 46 | 06 Feb 2021 |
12 | Evidence Affidavit Under Rule 46 (TOP) | 06 Feb 2021 |
13 | Annexure -1 under rule 46 | 06 Feb 2021 |
13 | Evidence Affidavit Under Rule 46 (TOP) | 06 Feb 2021 |
14 | Annexure -1 under rule 46 | 16 Aug 2021 |
14 | Evidence Affidavit Under Rule 46 (TOP) | 16 Aug 2021 |
15 | Annexure -1 under rule 46 | 16 Aug 2021 |
15 | Evidence Affidavit Under Rule 46 (TOP) | 16 Aug 2021 |
16 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 18 Oct 2021 |
2 | TM-M(EXPEDITED EXAMINATION) | 28 Jan 2020 |
3 | REPLY TO FORMALITY CHECK(MIS-F) | 30 Jan 2020 |
4 | TM-O(NOTICE OF OPPOSITION) | 14 Mar 2020 |
5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 13 Apr 2020 |
6 | TM-O(NOTICE OF OPPOSITION) | 09 Jun 2020 |
7 | Journal Copy | 31 Aug 2020 |
8 | Annexure -1 under rule 46 | 18 Dec 2020 |
9 | Annexure -1 under rule 46 | 18 Dec 2020 |
1 | Application(4419351) Keep Pending | 9666628 | 29 Jan 2020 | |
2 | Opposition Notice | 9947630 | 4885111 | 19 Mar 2020 |
3 | Opposition Counter Statement | 10170434 | 4921845 | 15 Jul 2020 |
4 | Opposition Notice | 10393501 | 4952779 | 09 Sep 2020 |
5 | Opposition Counter Statement | 10393526 | 4952780 | 09 Sep 2020 |
The application for Cetirizine hydrochloride syrup ip ctz was made on 24 January 2020.
The trademark applicant for Cetirizine hydrochloride syrup ip ctz is NOVITA HEALTHCARE.
Cetirizine hydrochloride syrup ip ctz is applied in class(es) 5.
Application for Cetirizine hydrochloride syrup ip ctz is on Opposed stage.
Application Id allotted to Cetirizine hydrochloride syrup ip ctz is 4419351.
Trademark agent or attorney for the application is G.S. Rijhwani & Co.
Cetirizine hydrochloride syrup ip ctz filed with the Intellectual property office as a DEVICE.